Skip to main content

Table 8 Associations between chemotherapy regimen and b-pCR in different combined groups

From: Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer

Combined group

Total

Stratification by b-pCR

n = 353

No

Yes

P Value

ER + PR + HER2-positive

73

51

22

0.554

AC-TPH

 

8

5

 

TCbPH

 

34

15

 

TPH

 

9

2

 

ER + PR-HER2-positive

72

36

36

0.850

AC-TPH

 

4

3

 

TCbPH

 

27

29

 

TPH

 

5

4

 

ER-PR-HER2-positive

208

68

140

0.022

AC-TPH

 

7

10

 

TCbPH

 

26

82

 

TPH

 

35

48

Â